- Home
- IMCR vs RKT Comparison
IMCR vs RKT Comparison
Compare IMCR & RKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- RKT
- Stock Information
- Founded
- IMCR 2008
- RKT 1985
- Country
- IMCR United Kingdom
- RKT United States
- Employees
- IMCR N/A
- RKT N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- RKT Finance: Consumer Services
- Sector
- IMCR Health Care
- RKT Finance
- Exchange
- IMCR Nasdaq
- RKT Nasdaq
- Market Cap
- IMCR 1.6B
- RKT 2.1B
- IPO Year
- IMCR 2021
- RKT 2020
- Fundamental
- Price
- IMCR $35.00
- RKT $13.67
- Analyst Decision
- IMCR Buy
- RKT Hold
- Analyst Count
- IMCR 10
- RKT 12
- Target Price
- IMCR $58.13
- RKT $14.21
- AVG Volume (30 Days)
- IMCR 389.0K
- RKT 14.9M
- Earning Date
- IMCR 08-07-2025
- RKT 07-31-2025
- Dividend Yield
- IMCR N/A
- RKT 5.85%
- EPS Growth
- IMCR N/A
- RKT N/A
- EPS
- IMCR N/A
- RKT N/A
- Revenue
- IMCR $333,581,000.00
- RKT $5,082,535,000.00
- Revenue This Year
- IMCR $26.82
- RKT $1.03
- Revenue Next Year
- IMCR $8.15
- RKT $33.42
- P/E Ratio
- IMCR N/A
- RKT $9,872.07
- Revenue Growth
- IMCR 25.75
- RKT 7.23
- 52 Week Low
- IMCR $23.15
- RKT $10.06
- 52 Week High
- IMCR $41.54
- RKT $21.38
- Technical
- Relative Strength Index (RSI)
- IMCR 59.78
- RKT 48.75
- Support Level
- IMCR $32.20
- RKT $13.24
- Resistance Level
- IMCR $35.75
- RKT $14.21
- Average True Range (ATR)
- IMCR 1.31
- RKT 0.54
- MACD
- IMCR 0.28
- RKT -0.12
- Stochastic Oscillator
- IMCR 84.94
- RKT 22.16
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About RKT Rocket Companies Inc.
Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and will also be the largest mortgage servicer in the US following its acquisition of the Mr. Cooper Group.